NEU neuren pharmaceuticals limited

Ann: 2023 Annual Report to shareholders, page-191

  1. 2,737 Posts.
    lightbulb Created with Sketch. 1050
    Yes it's not as straightforward as 50% or 90%. At 50% you basically have control as you can pass ordinary resolutions. At 75% you can pass special resolutions. As long as you still meet your fiduciary duty in the process this could see your asset sold to the predator/majority shareholder or similar. I would still expect a revised uplifted offer would go to minority holders if less than 90% take initial offer but definitely no guarantee of that.
    Last edited by nashezz: 29/04/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.96
Change
-0.140(1.07%)
Mkt cap ! $1.612B
Open High Low Value Volume
$13.20 $13.36 $12.82 $4.627M 354.8K

Buyers (Bids)

No. Vol. Price($)
1 7585 $12.96
 

Sellers (Offers)

Price($) Vol. No.
$13.03 3344 2
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.